AI Index / Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. (RXRX)
Recursion is integrating AI in drug discovery through automated synthesis platforms and active learning for precision chemistry and biology. The company relies on technology-enabled drug discovery processes to enhance efficiency in identifying novel drugs. The company is leveraging technology for precision chemistry and biology, aiming to reduce the time and cost of drug development. Recursion has several partnerships, including with NVIDIA and Exscientia to enhance capabilities in generative AI for molecular design.
Loading...
One is our pipeline really reflects the strategic application of Recursion OS and AI, where it matters the most.
- Najat Khan
Similar Companies in the Swift AI Index
Quotes from recursion-pharmaceuticals Executives About Artificial Intelligence and Generative AI
This is based on both data, and I'll talk through that, but also strategic considerations.
- Najat Khan
...another example of a molecule that was designed by a Recursion 2.0 platform, especially the generative AI piece...
- Najat Khan
...our generative AI design and ML-driven optimizations to create novel scaffolds with high safety margins...
- Najat Khan
...and then also some of the in vivo data that we're seeing, which is encouraging for us as a potential best-in-class therapy.
- Najat Khan